Internal Medicine, Gastroenterology · Chattanooga, TN
NPI
1689611626
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
979 E. Third Street, Suite C-825
Chattanooga, TN, 37403
Phone (423) 778-4830
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
722 services
Medicare patients, 2024
383
Average age 71
Drug cost, 2024
$1.0M
1,155 prescriptions
Company payments, 2025
$3,290
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven R Kessler was code 45385 (colonoscopy - lesion removal), 93 times for 93 patients. In total Steven R Kessler billed 722 services in 49 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 93 | 93 | $181.65 | $17K |
| 99213 Office E&M - Established | Office | 90 | 77 | $58.17 | $5,236 |
| 43239 Upper GI Endoscopy | Facility | 69 | 69 | $67.15 | $4,633 |
| 99231 Hospital E&M - Subsequent | Facility | 64 | 46 | $36.76 | $2,353 |
| 99222 Hospital E&M - Initial | Facility | 53 | 53 | $96.32 | $5,105 |
| 99213 Office E&M - Established | Facility | 31 | 30 | $49.64 | $1,539 |
| 43235 Upper GI Endoscopy | Facility | 28 | 28 | $62.65 | $1,754 |
| 99214 Office E&M - Established | Office | 28 | 26 | $79.20 | $2,218 |
| 45380 Lower GI Endoscopy - Other | Facility | 27 | 27 | $69.17 | $1,868 |
| 45378 Lower GI Endoscopy - Other | Facility | 25 | 25 | $99.56 | $2,489 |
| 99203 Office E&M - New | Office | 21 | 21 | $72.38 | $1,520 |
| 99204 Office E&M - New | Office | 18 | 18 | $103.63 | $1,865 |
| 74328 Digestive/Gastrointestinal | Facility | 16 | 13 | $17.28 | $276 |
| 43264 Upper GI Endoscopy | Facility | 14 | 11 | $130.60 | $1,828 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 11 | 11 | $162.20 | $1,784 |
By year: 2022 $65K for 730 services; 2023 $69K for 735 services; 2024 $65K for 722 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven R Kessler prescribed most often to Medicare patients was Pantoprazole Sodium, with 242 prescriptions and refills. In total Steven R Kessler wrote 1,155 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 242 | 404 | 75 | $2,647 |
| Linzess Linaclotide | 113 | 149 | 33 | $79K |
| Omeprazole Generic | 91 | 173 | 28 | $1,470 |
| Promethazine Hcl Generic | 79 | 79 | Under 11 | $627 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 57 | 57 | 55 | $9,753 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 51 | 51 | 14 | $1,137 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 49 | 49 | 49 | $2,871 |
| Dexlansoprazole Dr Dexlansoprazole | 35 | 67 | Under 11 | $9,101 |
| Famotidine Generic | 28 | 56 | Under 11 | $507 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 27 | 27 | 24 | $428 |
| Humira(Cf) Pen Adalimumab | 24 | 24 | Under 11 | $169K |
| Ondansetron Odt Ondansetron | 22 | 22 | Under 11 | $311 |
| Stelara Ustekinumab | 21 | 39 | Under 11 | $561K |
| Budesonide Ec Budesonide | 21 | 41 | Under 11 | $17K |
| Lubiprostone Generic | 21 | 25 | Under 11 | $1,936 |
Brand drugs: 330 claims; generic drugs: 825 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven R Kessler $3,290 ($3,290 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $802.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 42 | $802 |
| Boston Scientific Corporation BSX | 6 | $455 |
| Janssen Biotech, Inc. JNJ | 16 | $428 |
| Madrigal Pharmaceuticals MDGL | 10 | $217 |
| Celltrion USA Inc. 068270.KS | 13 | $183 |
| Lilly USA, LLC LLY | 4 | $170 |
| Pfizer Inc. PFE | 7 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 11 | $157 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $151 |
| Aimmune Therapeutics, Inc. | 4 | $99.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.